Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Campbell, JDM; Cook, G; Holyoake, TL
   Evolution of bone marrow transplantation - the original immunotherapy
   TRENDS IN IMMUNOLOGY
   
   J.D.M. Campbell et al., "Evolution of bone marrow transplantation - the original immunotherapy", TRENDS IMMU, 22(2), 2001, pp. 88-92
2. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
   Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells
   CYTOTHERAPY
   
   A.B. Dietz et al., "Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells", CYTOTHERAPY, 3(2), 2001, pp. 97-105
3. Szer, J; Lieschke, GJ
   Small molecule: large hopes
   INTERNAL MEDICINE JOURNAL
   
   J. Szer e G.J. Lieschke, "Small molecule: large hopes", INTERN M J, 31(7), 2001, pp. 382-383
4. Weisberg, E; Griffin, JD
   Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients
   DRUG RESISTANCE UPDATES
   
   E. Weisberg e J.D. Griffin, "Mechanisms of resistance imatinib (ST1571) in preclinical models and in leukemia patients", DRUG RESIST, 4(1), 2001, pp. 22-28
5. Benthin, M; Dallmann, I; Atzpodien, J
   13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro
   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
   
   M. Benthin et al., "13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro", CANC BIO R, 16(4), 2001, pp. 323-331
6. Honda, H; Hirai, H
   Model mice for BCR/ABL-positive leukemias
   BLOOD CELLS MOLECULES AND DISEASES
   
   H. Honda e H. Hirai, "Model mice for BCR/ABL-positive leukemias", BL CELL M D, 27(1), 2001, pp. 265-278
7. Vigneri, P; Wang, JYJ
   Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase
   NATURE MEDICINE
   
   P. Vigneri e J.Y.J. Wang, "Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase", NAT MED, 7(2), 2001, pp. 228-234
8. Fioretos, T; Panagopoulos, I; Lassen, C; Swedin, A; Billstrom, R; Isaksson, M; Strombeck, B; Olofsson, T; Mitelman, F; Johansson, B
   Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL
   GENES CHROMOSOMES & CANCER
   
   T. Fioretos et al., "Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL", GENE CHROM, 32(4), 2001, pp. 302-310
9. Jeffs, AR; Wells, E; Morris, CM
   Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions
   GENES CHROMOSOMES & CANCER
   
   A.R. Jeffs et al., "Nonrandom distribution of interspersed repeat elements in the BCR and ABLIgenes and its relation to breakpoint cluster regions", GENE CHROM, 32(2), 2001, pp. 144-154
10. Clark, RE; Christmas, SE
    BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia
    LEUKEMIA & LYMPHOMA
    
    R.E. Clark e S.E. Christmas, "BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia", LEUK LYMPH, 42(5), 2001, pp. 871-880
11. Lindauer, M; Fischer, T
    Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits
    LEUKEMIA & LYMPHOMA
    
    M. Lindauer e T. Fischer, "Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - Clinical benefits", LEUK LYMPH, 41(5-6), 2001, pp. 523-533
12. Shiratsuchi, M; Muta, K; Minami, R; Motomura, S; Suehiro, Y; Abe, Y; Shiokawa, S; Umemura, T; Fukui, T; Nishimura, J; Nawata, H
    Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression
    LEUKEMIA & LYMPHOMA
    
    M. Shiratsuchi et al., "Aberrant BCR-ABL transcript with intronic insertion in a patient with Philadelphia chromosome-positive chronic myeloid leukemia: Implications for disease progression", LEUK LYMPH, 41(3-4), 2001, pp. 411-415
13. Xie, SH; Wang, Y; Liu, JX; Sun, T; Wilson, MB; Smithgall, TE; Arlinghaus, RB
    Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation
    ONCOGENE
    
    S.H. Xie et al., "Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation", ONCOGENE, 20(43), 2001, pp. 6188-6195
14. Lin, F; Monaco, G; Sun, T; Liu, JX; Lin, H; Stephens, C; Belmont, J; Arlinghaus, RB
    BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model
    ONCOGENE
    
    F. Lin et al., "BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model", ONCOGENE, 20(15), 2001, pp. 1873-1881
15. Ko, BS; Tang, JL; Tsai, W; Chen, YC; Wang, CH; Sheng, MC; Lin, DT; Lin, KH; Tien, HF
    Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
    ANNALS OF HEMATOLOGY
    
    B.S. Ko et al., "Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan", ANN HEMATOL, 80(9), 2001, pp. 510-515
16. Wakayama, T; Maniwa, Y; Ago, H; Kakazu, N; Abe, T
    A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    T. Wakayama et al., "A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript", INT J HEMAT, 74(1), 2001, pp. 58-63
17. Maru, Y
    Molecular biology of chronic myeloid leukemia
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    Y. Maru, "Molecular biology of chronic myeloid leukemia", INT J HEMAT, 73(3), 2001, pp. 308-322
18. Hoeijmakers, JHJ
    From xeroderma pigmentosum to the biological clock contributions of Dirk Bootsma to human genetics
    MUTATION RESEARCH-DNA REPAIR
    
    J.H.J. Hoeijmakers, "From xeroderma pigmentosum to the biological clock contributions of Dirk Bootsma to human genetics", MUT R-DNA R, 485(1), 2001, pp. 43-59
19. Wakoff, AR; Porter, DL
    The biology and treatment of chronic myelogenous leukemia - The Brunstein/McGlave article reviewed
    ONCOLOGY-NEW YORK
    
    A.R. Wakoff e D.L. Porter, "The biology and treatment of chronic myelogenous leukemia - The Brunstein/McGlave article reviewed", ONCOLOGY-NY, 15(1), 2001, pp. 31-32
20. Bruecher-Encke, B; Griffin, JD; Neel, BG; Lorenz, U
    Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation
    LEUKEMIA
    
    B. Bruecher-Encke et al., "Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation", LEUKEMIA, 15(9), 2001, pp. 1424-1432
21. Damiano, JS; Hazlehurst, LA; Dalton, WS
    Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation
    LEUKEMIA
    
    J.S. Damiano et al., "Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation", LEUKEMIA, 15(8), 2001, pp. 1232-1239
22. Horibe, K; Tsukimoto, I; Ohno, R
    Clinicopathologic characteristics of leukemia in Japanese children and young adults
    LEUKEMIA
    
    K. Horibe et al., "Clinicopathologic characteristics of leukemia in Japanese children and young adults", LEUKEMIA, 15(8), 2001, pp. 1256-1261
23. Seiter, K; Feldman, EJ; Sreekantaiah, C; Pozzuoli, M; Weisberger, J; Liu, D; Papageorgio, C; Weiss, M; Kancherla, R; Ahmed, T
    Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy
    LEUKEMIA
    
    K. Seiter et al., "Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy", LEUKEMIA, 15(6), 2001, pp. 963-970
24. Pui, CH; Sailan, S; Relling, MV; Masera, G; Evans, WE
    International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000
    LEUKEMIA
    
    C.H. Pui et al., "International childhood Acute Lymphoblastic Leukemia workshop: Sausalito, CA, 30 November-1 December 2000", LEUKEMIA, 15(5), 2001, pp. 707-715
25. Yu, Q; Brain, J; Laneuville, P; Osmond, DG
    Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190(bcr/abl) transgenic mice
    LEUKEMIA
    
    Q. Yu et al., "Suppressed apoptosis of pre-B cells in bone marrow of pre-leukemic p190(bcr/abl) transgenic mice", LEUKEMIA, 15(5), 2001, pp. 819-827
26. Shteper, PJ; Siegfried, Z; Asimakopoulos, FA; Palumbo, GA; Rachmilewitz, EA; Ben-Neriah, Y; Ben-Yehuda, D
    ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL
    LEUKEMIA
    
    P.J. Shteper et al., "ABL1 methylation in Ph-positive ALL is exclusively associated with the P210 form of BCR-ABL", LEUKEMIA, 15(4), 2001, pp. 575-582
27. Kawaguchi, Y; Jinnai, I; Nagai, K; Yagasaki, F; Yakata, Y; Matsuo, T; Kuriyama, K; Tomonaga, M
    Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells
    LEUKEMIA
    
    Y. Kawaguchi et al., "Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells", LEUKEMIA, 15(4), 2001, pp. 590-594
28. Tabernero, MD; Bortoluci, AM; Alaejos, I; Lopez-Berges, MC; Rasillo, A; Garcia-Sanz, R; Garcia, M; Sayagues, JM; Gonzalez, M; Mateo, G; San Miguel, JF; Orfao, A
    Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression
    LEUKEMIA
    
    M.D. Tabernero et al., "Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression", LEUKEMIA, 15(3), 2001, pp. 406-414
29. Ferrero, D; Foli, C; Giaretta, F; Argentino, C; Rus, C; Pileri, A
    Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon
    LEUKEMIA
    
    D. Ferrero et al., "Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon", LEUKEMIA, 15(3), 2001, pp. 422-429
30. Miyamoto, N; Sugita, K; Goi, K; Inukai, T; Iijima, K; Tezuka, T; Kojika, S; Nakamura, M; Kagami, K; Nakazawa, S
    The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome
    LEUKEMIA
    
    N. Miyamoto et al., "The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome", LEUKEMIA, 15(11), 2001, pp. 1758-1768
31. Kramer, A; Loffler, H; Bergmann, J; Hochhaus, A; Hehlmann, R
    Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
    LEUKEMIA
    
    A. Kramer et al., "Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia", LEUKEMIA, 15(1), 2001, pp. 62-68
32. Kurzrock, R; Bueso-Ramos, CE; Kantarjian, H; Freireich, E; Tucker, SL; Siciliano, M; Pilat, S; Talpaz, M
    BCR rearrangement-negative chronic myelogenous leukemia revisited
    JOURNAL OF CLINICAL ONCOLOGY
    
    R. Kurzrock et al., "BCR rearrangement-negative chronic myelogenous leukemia revisited", J CL ONCOL, 19(11), 2001, pp. 2915-2926
33. Wu, JH; Suzuki, H; Zhou, YW; Liu, W; Yoshihara, M; Kato, M; Akhand, AA; Hayakawa, A; Takeuchi, K; Hossain, K; Kurosawa, M; Nakashima, I
    Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines
    JOURNAL OF CELLULAR BIOCHEMISTRY
    
    J.H. Wu et al., "Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines", J CELL BIOC, 82(2), 2001, pp. 200-214
34. Zanella, I; Rossi, G; Finazzi, D; Capucci, A; Albertini, A; Cariani, E
    Quantification of bcr/abl mRNA expression by a rapid real time reverse transcription-polymerase chain reaction assay in patients with chronic myeloidleukemia
    HAEMATOLOGICA
    
    I. Zanella et al., "Quantification of bcr/abl mRNA expression by a rapid real time reverse transcription-polymerase chain reaction assay in patients with chronic myeloidleukemia", HAEMATOLOG, 86(3), 2001, pp. 318-319
35. Marin, C; Martinez-Delgado, B; Melendez, B; Larrayoz, MJ; Martinez-Ramirez, A; Robledo, M; Cigudosa, JC; Calasanz, MJ; Benitez, J
    Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia
    HAEMATOLOGICA
    
    C. Marin et al., "Multiplex-polymerase chain reaction assay for the detection of prognostically significant translocations in acute lymphoblastic leukemia", HAEMATOLOG, 86(12), 2001, pp. 1254-1260
36. Kudoh, T; Suzuki, N; Hatakeyama, N; Mizue, N; Hori, T; Oda, T; Watanabe, J; Imamura, M; Chiba, S
    Successful unrelated cord blood transplantation in Philadelphia chromosomepositive acute lymphoblastic leukemia during pulmonary aspergillosis treated by anti-fungal therapy, granulocyte colony-stimulating factor-mobilized granulocytes and surgical resection: Case report
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    T. Kudoh et al., "Successful unrelated cord blood transplantation in Philadelphia chromosomepositive acute lymphoblastic leukemia during pulmonary aspergillosis treated by anti-fungal therapy, granulocyte colony-stimulating factor-mobilized granulocytes and surgical resection: Case report", JPN J CLIN, 31(6), 2001, pp. 290-293
37. Fan, EJ; Ying, H; Zhao, CH
    Human stem cell model to study signal transduction and molecular regulation mechanisms in CML
    CHINESE MEDICAL JOURNAL
    
    E.J. Fan et al., "Human stem cell model to study signal transduction and molecular regulation mechanisms in CML", CHIN MED J, 114(7), 2001, pp. 680-684
38. Dietz, AB; Litzow, MR; Gastineau, DA; Vuk-Pavlovic, S
    Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia
    CROATIAN MEDICAL JOURNAL
    
    A.B. Dietz et al., "Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: Example of chronic myelogenous leukemia", CROAT MED J, 42(4), 2001, pp. 428-435
39. Hicks, C; Keoshkerian, E; Gaudry, L; Lindeman, R
    CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    C. Hicks et al., "CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6", CANCER IMMU, 50(4), 2001, pp. 173-180
40. He, L; Feng, HP; Raymond, A; Kreeger, M; Zeng, Y; Graner, M; Whitesell, L; Katsanis, E
    Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    L. He et al., "Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice", CANCER IMMU, 50(1), 2001, pp. 31-40
41. Daheron, L; Zenz, T; Siracusa, LD; Brenner, C; Calabretta, B
    Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity
    NUCLEIC ACIDS RESEARCH
    
    L. Daheron et al., "Molecular cloning of Ian4: a BCR/ABL-induced gene that encodes an outer membrane mitochondrial protein with GTP-binding activity", NUCL ACID R, 29(6), 2001, pp. 1308-1316
42. Buchdunger, E; Matter, A; Druker, BJ
    Bcr-Abl inhibition as a modality of CML therapeutics
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    
    E. Buchdunger et al., "Bcr-Abl inhibition as a modality of CML therapeutics", BBA-REV CAN, 1551(1), 2001, pp. M11-M18
43. Jorgensen, HG; Holyoake, TL
    A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia
    HEMATOLOGICAL ONCOLOGY
    
    H.G. Jorgensen e T.L. Holyoake, "A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia", HEMATOL ONC, 19(3), 2001, pp. 89-106
44. Zhang, ZW; Subrahmanyam, R; Wong, R; Gross, AW; Ren, RB
    The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl
    MOLECULAR AND CELLULAR BIOLOGY
    
    Z.W. Zhang et al., "The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl", MOL CELL B, 21(3), 2001, pp. 840-853
45. Drummond, MW; Holyoake, TL
    Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?
    BLOOD REVIEWS
    
    M.W. Drummond e T.L. Holyoake, "Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?", BLOOD REV, 15(2), 2001, pp. 85-95
46. Maury, S; Belhadj, K; Chami, I; Kuentz, M; Cordonnier, C; Bories, D
    Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population
    BONE MARROW TRANSPLANTATION
    
    S. Maury et al., "Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population", BONE MAR TR, 28(7), 2001, pp. 717-720
47. Mahon, FX
    Chronic myelogenous leukemic and tyrosine kinase inhibitors.
    REVUE DE MEDECINE INTERNE
    
    F.X. Mahon, "Chronic myelogenous leukemic and tyrosine kinase inhibitors.", REV MED IN, 22(9), 2001, pp. 894-899
48. Thiele, J; Kvasnicka, HM; Beelen, DW; Leder, LD; Schaefer, UW
    Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients
    HISTOLOGY AND HISTOPATHOLOGY
    
    J. Thiele et al., "Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients", HIST HISTOP, 16(1), 2001, pp. 213-226
49. Tanaka, K; Minamihisamatu, M; Yagi, S; Kyo, T; Dohy, H; Kamada, N
    Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization
    EXPERIMENTAL ONCOLOGY
    
    K. Tanaka et al., "Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization", EXP ONCOL, 23(1), 2001, pp. 29-38
50. Gonzalez, FA; Anguita, E; Mora, A; Asenjo, S; Lopez, I; Polo, M; Villegas, A
    Deletion of BCR region 3 ' in chronic myelogenous leukemia
    CANCER GENETICS AND CYTOGENETICS
    
    F.A. Gonzalez et al., "Deletion of BCR region 3 ' in chronic myelogenous leukemia", CANC GENET, 130(1), 2001, pp. 68-74
51. Mohr, B; Bornhauser, M; Platzbecker, U; Freiberg-Richter, J; Naumann, R; Prange-Krex, G; Mohm, J; Kroschinsky, F; Ehninger, G; Thiede, C
    Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals
    CANCER GENETICS AND CYTOGENETICS
    
    B. Mohr et al., "Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals", CANC GENET, 127(2), 2001, pp. 111-117
52. Ge, XQ; Tanaka, K; Mansyur, A; Tazawa, H; Iwato, K; Kyo, T; Dohy, H; Kamada, N
    Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region
    CANCER GENETICS AND CYTOGENETICS
    
    X.Q. Ge et al., "Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region", CANC GENET, 126(2), 2001, pp. 102-110
53. Naumann, S; Reutzel, D; Speicher, M; Decker, HJ
    Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization
    LEUKEMIA RESEARCH
    
    S. Naumann et al., "Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization", LEUK RES, 25(4), 2001, pp. 313-322
54. Mori, T; Manabe, A; Tsuchida, M; Hanada, R; Yabe, H; Ohara, A; Saito, T; Nakazawa, S
    Allogeneic bone marrow transplantation in first remission rescues childrenwith Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    T. Mori et al., "Allogeneic bone marrow transplantation in first remission rescues childrenwith Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13", MED PED ONC, 37(5), 2001, pp. 426-431
55. McCabe, MG; Broadbent, V; Williams, DM
    Unusual cause of extradural haemorrhage
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    M.G. McCabe et al., "Unusual cause of extradural haemorrhage", MED PED ONC, 36(6), 2001, pp. 654-656
56. Oudat, R; Khan, Z; Glassman, AB
    Detection of trisomy 8 in Philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement
    ANNALS OF CLINICAL AND LABORATORY SCIENCE
    
    R. Oudat et al., "Detection of trisomy 8 in Philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement", ANN CLIN L, 31(1), 2001, pp. 68-74
57. Witte, O
    The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology
    SEMINARS IN HEMATOLOGY
    
    O. Witte, "The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology", SEM HEMATOL, 38(3), 2001, pp. 3-8
58. Gorre, ME; Mohammed, M; Ellwood, K; Hsu, N; Paquette, R; Rao, PN; Sawyers, CL
    Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
    SCIENCE
    
    M.E. Gorre et al., "Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification", SCIENCE, 293(5531), 2001, pp. 876-880
59. Dai, ZH; Kerzic, P; Schroeder, WG; McNiece, IK
    Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    Z.H. Dai et al., "Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis", J BIOL CHEM, 276(31), 2001, pp. 28954-28960
60. Parada, Y; Banerji, L; Glassford, J; Lea, NC; Collado, M; Rivas, C; Lewis, JL; Gordon, MY; Thomas, NSB; Lam, EWF
    BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27(Kip1) expression
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    Y. Parada et al., "BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27(Kip1) expression", J BIOL CHEM, 276(26), 2001, pp. 23572-23580
61. Kain, KH; Klemke, RL
    Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    K.H. Kain e R.L. Klemke, "Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes", J BIOL CHEM, 276(19), 2001, pp. 16185-16192
62. Deininger, MWN; Vieira, SAD; Parada, Y; Banerji, L; Lam, EWF; Peters, G; Mahon, FX; Kohler, T; Goldman, JM; Melo, JV
    Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts
    CANCER RESEARCH
    
    M.W.N. Deininger et al., "Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts", CANCER RES, 61(21), 2001, pp. 8005-8013
63. Goetz, AW; van der Kuip, H; Maya, R; Oren, M; Aulitzky, WE
    Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
    CANCER RESEARCH
    
    A.W. Goetz et al., "Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells", CANCER RES, 61(20), 2001, pp. 7635-7641
64. Wang, Y; Liu, JX; Wu, Y; Luo, WP; Lin, SH; Lin, H; Hawk, N; Sun, T; Guo, JQ; Estrov, Z; Talpaz, M; Champlin, R; Arlinghaus, RB
    Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death
    CANCER RESEARCH
    
    Y. Wang et al., "Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death", CANCER RES, 61(1), 2001, pp. 138-144
65. Etienne, G; Mahon, FX
    Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia
    BULLETIN DU CANCER
    
    G. Etienne e F.X. Mahon, "Leukemogenesis and new therapy development: the example of chronic myelogenous leukemia", B CANCER, 88(7), 2001, pp. 651-658
66. Donadieu, J; Hill, C
    Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review
    BRITISH JOURNAL OF HAEMATOLOGY
    
    J. Donadieu e C. Hill, "Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review", BR J HAEM, 115(1), 2001, pp. 34-45
67. Sica, S; Chiusolo, P; Zollino, M; Sora, F; Piccirillo, N; Laurenti, L; Reddiconto, G; Leone, G
    The association of severe aplastic anaemia with the Philadelphia chromosome and the BCR/ABL transcript
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. Sica et al., "The association of severe aplastic anaemia with the Philadelphia chromosome and the BCR/ABL transcript", BR J HAEM, 114(4), 2001, pp. 961-962
68. Holyoake, TL
    Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: Lessons to be learned from the laboratory
    BRITISH JOURNAL OF HAEMATOLOGY
    
    T.L. Holyoake, "Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: Lessons to be learned from the laboratory", BR J HAEM, 113(1), 2001, pp. 11-23
69. Ramakers-van Woerden, NL; Pieters, R; Slater, RM; Loonen, AH; Beverloo, HB; van Drunen, E; Heyman, M; Moreno, TC; Rots, MG; van Wering, ER; Kamps, WA; Janka-Schaub, GE; Veerman, AJP
    In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    N.L. Ramakers-van Woerden et al., "In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia", BR J HAEM, 112(3), 2001, pp. 680-690
70. van der Kuip, H; Goetz, AW; Miething, C; Duyster, J; Aulitzky, WE
    Adhesion to fibronectin selectively protects Bcr-Abl(+) cells from DNA damage-induced apoptosis
    BLOOD
    
    H. van der Kuip et al., "Adhesion to fibronectin selectively protects Bcr-Abl(+) cells from DNA damage-induced apoptosis", BLOOD, 98(5), 2001, pp. 1532-1541
71. Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; Bourdon, A; Bonner, PLR; Wang, LH; Christmas, SE; Travers, PJ; Creaser, CS; Rees, RC; Madrigal, JA
    Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
    BLOOD
    
    R.E. Clark et al., "Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein", BLOOD, 98(10), 2001, pp. 2887-2893
72. Zhao, RC; Jiang, YH; Verfaillie, CM
    A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector
    BLOOD
    
    R.C. Zhao et al., "A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector", BLOOD, 97(8), 2001, pp. 2406-2412
73. Kano, Y; Akutsu, M; Tsunoda, S; Mano, H; Sato, Y; Honma, Y; Furukawa, Y
    In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents
    BLOOD
    
    Y. Kano et al., "In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents", BLOOD, 97(7), 2001, pp. 1999-2007
74. Sun, XM; Layton, JE; Elefanty, A; Lieschke, GJ
    Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL-expressing cells, demonstrating synergy between AG490 andSTI571
    BLOOD
    
    X.M. Sun et al., "Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL-expressing cells, demonstrating synergy between AG490 andSTI571", BLOOD, 97(7), 2001, pp. 2008-2015
75. Peters, DG; Hoover, RR; Gerlach, MJ; Koh, EY; Zhang, HY; Choe, K; Kirschmeier, P; Bishop, WR; Daley, GQ
    Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia
    BLOOD
    
    D.G. Peters et al., "Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia", BLOOD, 97(5), 2001, pp. 1404-1412
76. Tomasson, MH; Williams, IR; Li, SG; Kutok, J; Cain, D; Gillessen, S; Dranoff, G; Van Etten, RA; Gilliland, DG
    Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3
    BLOOD
    
    M.H. Tomasson et al., "Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3", BLOOD, 97(5), 2001, pp. 1435-1441
77. Zhang, XW; Wong, R; Hao, SX; Pear, WS; Ren, RB
    The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype
    BLOOD
    
    X.W. Zhang et al., "The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype", BLOOD, 97(1), 2001, pp. 277-287
78. Sun, T; Campbell, M; Gordon, W; Arlinghaus, RB
    Preparation and application of antibodies to phosphoamino acid sequences
    BIOPOLYMERS
    
    T. Sun et al., "Preparation and application of antibodies to phosphoamino acid sequences", BIOPOLYMERS, 60(1), 2001, pp. 61-75
79. Suzuki, R; Takemura, K; Tsutsumi, M; Nakamura, S; Hamajima, N; Seto, M
    Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma
    AMERICAN JOURNAL OF PATHOLOGY
    
    R. Suzuki et al., "Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma", AM J PATH, 159(2), 2001, pp. 425-429
80. Stocks, MR; Rabbitts, TH
    Masked antisense: a molecular configuration for discriminating similar RNAtargets
    EMBO REPORTS
    
    M.R. Stocks e T.H. Rabbitts, "Masked antisense: a molecular configuration for discriminating similar RNAtargets", EMBO REP, 1(1), 2000, pp. 59-64
81. Snyder, DS
    Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    
    D.S. Snyder, "Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia", BIOL BLOOD, 6(6), 2000, pp. 597-603
82. Salesse, S; Lagarde, V; Ged, C; De Verneuil, H; Reiffers, J; Mahon, FX
    Retroviral coexpression of IFN-alpha and IFN-gamma genes and inhibitory effects in chronic myeloid leukemia cells
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    
    S. Salesse et al., "Retroviral coexpression of IFN-alpha and IFN-gamma genes and inhibitory effects in chronic myeloid leukemia cells", J INTERF CY, 20(6), 2000, pp. 577-587
83. Fajkusova, L; Fajkus, J; Polackova, K; Fulnecek, J; Dvorakova, D; Kahulcova, E
    Detailed mapping of methylcytosine positions at the CpG island surroundingthe Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173
    BLOOD CELLS MOLECULES AND DISEASES
    
    L. Fajkusova et al., "Detailed mapping of methylcytosine positions at the CpG island surroundingthe Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173", BL CELL M D, 26(3), 2000, pp. 193-204
84. Svingen, PA; Tefferi, A; Kottke, TJ; Kaur, G; Narayanan, VL; Sausville, EA; Kaufmann, SH
    Effect of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro
    CLINICAL CANCER RESEARCH
    
    P.A. Svingen et al., "Effect of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro", CLIN CANC R, 6(1), 2000, pp. 237-249
85. Buckle, AM; Mottram, R; Pierce, A; Lucas, GS; Russell, N; Miyan, JA; Whetton, AD
    The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells
    MOLECULAR MEDICINE
    
    A.M. Buckle et al., "The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells", MOL MED, 6(10), 2000, pp. 892-902
86. Kabarowski, JHS; Witte, ON
    Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia
    STEM CELLS
    
    J.H.S. Kabarowski e O.N. Witte, "Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia", STEM CELLS, 18(6), 2000, pp. 399-408
87. Colleoni, GWB; Jhanwar, SC; Ladanyi, M; Chen, BY
    Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias
    DIAGNOSTIC MOLECULAR PATHOLOGY
    
    G.W.B. Colleoni et al., "Comparison of a multiplex reverse transcriptase-polymerase chain reaction for BCR-ABL to fluorescence in situ hybridization, southern blotting, and conventional cytogenetics in the monitoring of patients with Ph1-positive leukemias", DIAGN MOL P, 9(4), 2000, pp. 203-209
88. Pagano, L; Pulsoni, A; Mele, L; Leone, G
    Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy
    LEUKEMIA & LYMPHOMA
    
    L. Pagano et al., "Clinical and epidemiological features of acute lymphoblastic leukemia following a previous malignancy", LEUK LYMPH, 39(5-6), 2000, pp. 465-475
89. Guinn, BA; Evely, RS; Walsh, V; Gilkes, AF; Burnett, AK; Mills, KI
    An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells
    LEUKEMIA & LYMPHOMA
    
    B.A. Guinn et al., "An in vivo and in vitro comparison of the effects of b2-a2 and b3-a2 p210BCR-ABL splice variants on murine 32D cells", LEUK LYMPH, 37(3-4), 2000, pp. 393-404
90. Faderl, S; Kantarjian, HM; Thomas, DA; Cortes, J; Giles, F; Pierce, S; Albitar, M; Estrov, Z
    Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    S. Faderl et al., "Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia", LEUK LYMPH, 36(3-4), 2000, pp. 263-273
91. Warashina, M; Kuwabara, T; Taira, K
    Working at the cutting edge: the creation of allosteric ribozymes
    STRUCTURE
    
    M. Warashina et al., "Working at the cutting edge: the creation of allosteric ribozymes", STRUCTURE, 8(11), 2000, pp. R207-R212
92. Salloukh, HF; Vowles, I; Heisterkamp, N; Groffen, J; Laneuville, P
    Early events in leukemogenesis in P190Bcr-abl transgenic mice
    ONCOGENE
    
    H.F. Salloukh et al., "Early events in leukemogenesis in P190Bcr-abl transgenic mice", ONCOGENE, 19(38), 2000, pp. 4362-4374
93. Nieborowska-Skorska, M; Slupianek, A; Skorski, T
    Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells
    ONCOGENE
    
    M. Nieborowska-Skorska et al., "Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells", ONCOGENE, 19(36), 2000, pp. 4117-4124
94. Carayol, G; Giron-Michel, J; Azzarone, B; Castagna, L; Cambier, N; Mishal, Z; Bourhis, JH; Chouaib, S; Caignard, A
    Altered natural killer cell differentiation in CD34(+) progenitors from chronic myeloid leukemia patients
    ONCOGENE
    
    G. Carayol et al., "Altered natural killer cell differentiation in CD34(+) progenitors from chronic myeloid leukemia patients", ONCOGENE, 19(23), 2000, pp. 2758-2766
95. Elmaagacli, AH; Beelen, DW; Opalka, B; Seeber, S; Schafer, UW
    The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
    ANNALS OF HEMATOLOGY
    
    A.H. Elmaagacli et al., "The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage", ANN HEMATOL, 79(8), 2000, pp. 424-431
96. Nakamura, H; Inokuchi, K; Hanawa, H; Yamaguchi, H; Tamura, H; Tajika, K; Dan, K
    A case of chronic myeloid leukemia with minor bcr-abl transcript followingfluorouracil therapy for esophageal carcinoma
    ANNALS OF HEMATOLOGY
    
    H. Nakamura et al., "A case of chronic myeloid leukemia with minor bcr-abl transcript followingfluorouracil therapy for esophageal carcinoma", ANN HEMATOL, 79(7), 2000, pp. 396-401
97. Miura, I; Takahashi, N; Kobayashi, Y; Saito, K; Miura, AB
    Molecular cytogenetics of stem cells: Target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    I. Miura et al., "Molecular cytogenetics of stem cells: Target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting", INT J HEMAT, 72(3), 2000, pp. 310-317
98. Nawata, R; Shinohara, K; Yamada, T; Takahashi, T; Katsuki, K; Takeda, K; Kameda, N; Ariyoshi, K; Ota, I; Muraki, K
    Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: Sequential cytogenetic and molecular analyses
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    R. Nawata et al., "Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: Sequential cytogenetic and molecular analyses", INT J HEMAT, 71(4), 2000, pp. 353-358
99. van den Berg, H; van der Lelie, J
    Acute lymphoblastic leukaemia in puberty and adolescence
    ANNALS OF ONCOLOGY
    
    H. van den Berg e J. van der Lelie, "Acute lymphoblastic leukaemia in puberty and adolescence", ANN ONCOL, 11(11), 2000, pp. 1375-1379
100. Andreasson, P; Hoglund, M; Bekassy, AN; Garwicz, S; Heldrup, J; Mitelman, F; Johansson, B
     Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias
     EUROPEAN JOURNAL OF HAEMATOLOGY
     
     P. Andreasson et al., "Cytogenetic and FISH studies of a single center consecutive series of 152 childhood acute lymphoblastic leukemias", EUR J HAEMA, 65(1), 2000, pp. 40-51